Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
October 11, 2001

Aventis Pharmaceuticals to Repeat Successful Breast Cancer Patient Outreach Program

'Connection Cards'(TM) to Be Offered During Breast Cancer Awareness Month

Aventis Pharmaceuticals today announced it will once again offer "Connection Cards"(TM), an outreach program for breast cancer patients who are undergoing treatment. "Connection Cards" are designed to help patients develop a support network of institutions and professional experts. The program is available beginning today to coincide with the start of National Breast Cancer Awareness Month.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000501/NYM197 )

According to the American Cancer Society, an estimated 192,200 new cases of invasive breast cancer will be reported in women in the United States this year. Women undergoing treatment may obtain the Connection Cards from their oncologists.

The "Connection Cards" program includes 10 custom-designed, all-occasion note cards and envelopes, a matching 30-minute prepaid long-distance phone card, and a credit card-sized reference card containing toll-free numbers and Web site addresses for nationally recognized breast cancer organizations, including the American Cancer Society, Living Beyond Breast Cancer, the National Alliance of Breast Cancer Organizations (NABCO), the National Breast Cancer Coalition (NBCC), the Susan G. Komen Breast Cancer Foundation and Y-ME National Breast Cancer Organization. The reference card also provides a toll-free phone number and Internet address for "Living With It," Aventis' new comprehensive support program for women with recurrent breast cancer. With the completion of this year's program, nearly 100,000 Connection Cards kits will be distributed to patients.

"After a breast cancer diagnosis, every woman needs state-of-the-art care, information to help her make the best decisions, connection to practical and expert resources, and the support and comfort of family and friends," said Amy S. Langer, executive director of the National Alliance of Breast Cancer Organizations (NABCO) and a breast cancer survivor. "This program will offer patients a welcome and meaningful gift."

Breast cancer is the most common cancer among women, excluding skin cancer, and the second leading cause of cancer death among women in the United States. The American Cancer Society estimates that in 2001 there will be about 40,600 deaths from breast cancer in the United States.

About Aventis Pharmaceuticals

Aventis Pharmaceuticals conducts the U.S. business of Aventis Pharma AG. With headquarters in Bridgewater, N.J., Aventis Pharmaceuticals focuses its activities on important therapeutic areas such as cardiology, oncology, anti-infectives, arthritis, allergy and respiratory, diabetes and central nervous system.

Aventis Pharma AG is the pharmaceutical company of Aventis S.A. (NYSE: AVE) . Aventis Pharma is dedicated to treating and preventing human disease through the discovery, development, manufacture and sale of innovative pharmaceutical products aimed at fulfilling unmet medical needs. The corporate headquarters of Aventis Pharma is in Frankfurt, Germany. Aventis Pharma is comprised of Aventis Pasteur, a world leader in vaccines, headquartered in Lyon, France, and Aventis Behring, a world leader in therapeutic proteins, headquartered in King of Prussia, Pa.

Aventis S.A., a world leader in pharmaceuticals and agriculture, is headquartered in Strasbourg, France. The company employs approximately 92,500 people in more than 120 countries. Aventis was launched in December 1999 through the merger of Hoechst AG and Rhone-Poulenc S.A. To receive a copy of this or any recent release, visit the Aventis Pharmaceuticals U.S. Web site at http://www.aventispharma-us.com/ or call 800-207-8049.

Statements in this news release other than historical information are forward-looking statements subject to risks and uncertainties. Actual results could differ materially depending on factors such as the availability of resources, the timing and effects of regulatory actions, the strength of competition, the outcome of litigation, and the effectiveness of patent protection. Additional information regarding risks and uncertainties is set forth in the current Annual Report on Form 20-F of Aventis on file with the Securities and Exchange Commission.

Source: PRNewswire

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.

###

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.